Paragon Bioservices

Catalent Gosselies cell therapy site
Manufacturing

Catalent adds Belgian site to cell and gene therapy portfolio

Catalent has acquired Bone Therapeutics' cell and gene therapy site in Gosselies, Belgium, to add to its growing "center of excellence" there.
Kyle Blankenship Oct 29, 2020 11:33am
Paragon Bioservices

Catalent's new prize adding capacity to make gene therapies

May 21, 2019 9:23am
Paragon Bioservices

Catalent pulls off $1.2B deal for gene therapy CDMO Paragon

Apr 15, 2019 11:07am